Journal article
Antifungal pharmacotherapy for neonatal candidiasis
Seminars in perinatology, Vol.27(5), pp.365-374
2003
DOI: 10.1016/S0146-0005(03)00060-0
PMID: 14626500
Abstract
Candida is a leading cause of late onset infection (>3 days of age) in the premature infant. Therefore, decisions about the diagnosis and management of infections caused by
Candida are commonplace in the neonatal intensive care unit. Despite this fact, there are few comparative trials about treatment of neonatal
Candida infections to guide the practitioner. New antifungals have been developed in the past decade and some clinical experience has been reported that can be used to guide the treatment of infants with serious
Candida infections. This article reviews recent pertinent data with regard to dosing guidelines, efficacy, and toxicities of available systemic antifungal agents in the newborn.
Details
- Title: Subtitle
- Antifungal pharmacotherapy for neonatal candidiasis
- Creators
- Joseph M Bliss - Department of Pediatrics, Women and Infants’ Hospital of Rhode Island, Brown University School of Medicine, Providence, RI, USAMelanie Wellington - Department of Pediatrics, The University of Rochester School of Medicine and Dentistry, Rochester, NY, USAFrancis Gigliotti - Department of Pediatrics, The University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
- Resource Type
- Journal article
- Publication Details
- Seminars in perinatology, Vol.27(5), pp.365-374
- Publisher
- Elsevier Inc
- DOI
- 10.1016/S0146-0005(03)00060-0
- PMID
- 14626500
- ISSN
- 0146-0005
- eISSN
- 1558-075X
- Language
- English
- Date published
- 2003
- Academic Unit
- Stead Family Department of Pediatrics; Infectious Disease (Pediatrics)
- Record Identifier
- 9984093486202771
Metrics
21 Record Views